Highlights
NASDAQ: AKBA       Akebia Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
7.79   -0.04 (0.51%)  7.76 - 7.94  199,996

Overview

 
Avg Volume (4 weeks):1,482,577
4 Weeks Range:6.19 - 8.74
4 Weeks Price Volatility (%):
62.75%
52 Weeks Range:2.99 - 9.30
52 Weeks Price Volatility (%):
76.07%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

  Be the first to like this.
 


 

1576  3681  599  3108 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 ACHN 6.760.00 
 GE 12.755+1.025 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 AMD 46.49-4.04 
 ECA 3.79-0.25 
 BBT 54.24+0.75 
 CHK 0.535+0.017 
Partners & Brokers